Banu Coşkun YILMAZ, Gülhan TEMEL OREKİCİ, Savaş AKTAŞ, Meryem İlkay KARAGÜL, Mustafa YILMAZ

GDF9 and BMP15 Expressions and Fine Structure Changes During Folliculogenesis in Polycystic Ovary Syndrome

Background: Polycystic ovary syndrome is the mostfrequently seen endocrine disorder in women ofreproductive age with a prevalence of about 10%.Aims: To investigate the efficiency of growthdifferentiation factor 9 and bone morphogenetic protein15 during folliculogenesis in a dehydroepiandrosteroneinducedmouse Polycystic ovary syndrome model.Study Design: Animal experimentation.Methods: Mice were divided into 3 groups: control,vehicle and Polycystic ovary syndrome. Polycysticovary syndrome model mice were developed by theinjection of dehydroepiandrosterone dissolved in 0.1 mLof sesame oil. Ovarian tissues were examined for growthdifferentiation factor 9 and bone morphogenetic protein15 using immunofluorescent labelling and electronmicroscopic examinations.Results: The immunoreactivity of growth differentiationfactor 9 and bone morphogenetic protein 15 proteinsdecreased (p

PDF

___

Daniilidis A, Dinas K. Long term health consequences of polycystic ovarian syndrome: a review analysis. Hippokratia 2009;13:90-2.
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219-31.
Dumesic DA, Abbott DH, Padmanabhan V. Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord 2007;8:127-41.
Oktem O, Urman B. Understanding follicle growth in vivo. Hum Reprod 2010;25:2944-54.
Elvin JA, Yan C, Matzuk MM. Oocyte-expressed TGF-beta superfamily members in female fertility. Mol Cell Endocrinol 2000;159:1-5.
Dumesic DA, Abbott DH. Implications of polycystic ovary syndrome on oocyte development. Semin Reprod Med 2008;26:53-61.
Peng J, Li Q, Wigglesworth K, Rangarajan A, Kattamuri C, Peterson RT, et al. Growth differentiation factor 9: bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functions. Proc Natl Acad Sci U S A 2013;110:E776-85.
de Resende LO, Vireque AA, Santana LF, Moreno DA, de Sá Rosa e Silva AC, Ferriani RA, et al. Single-cell expression analysis of BMP15 and GDF9 in mature oocytes and BMPR2 in cumulus cells of women with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation. J Assist Reprod Genet 2012;29:1057-65.
Wei LN, Li LL, Fang C, Huang R, Liang XY. Inhibitory effects of controlled ovarian stimulation on the expression of GDF9 and BMP15 in oocytes from women with PCOS. J Assist Reprod Genet 2013;30:1313-18.
Otsuka F, McTavish KJ, Shimasaki S. Integral role of GDF-9 and BMP-15 in ovarian function. Mol Reprod Dev 2011;78:9-21.
Carabatsos MJ, Elvin J, Matzuk MM, Albertini DF. Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev Biol 1998;204:373-84.
Wu YT, Tang L, Cai J, Lu XE, Xu J, Zhu XM, et al. High bone morphogenetic protein-15 level in follicular fluid is associated with high quality oocyte and subsequent embryonic development. Hum Reprod 2007;22:1526-31.
Zhao SY, Qiao J, Chen YJ, Liu P, Li J, Yan J. Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary syndrome. Fertil Steril 2010;94:261-7.
Wei LN, Liang XY, Fang C, Zhang MF. Abnormal expression of growth differentiation factor 9 and bone morphogenetic protein 15 in stimulated oocytes during maturation from women with polycystic ovary syndrome. Fertil Steril 2011;96:464-8.
Wei LN, Huang R, Li LL, Fang C, Li Y, Liang XY. Reduced and delayed expression of GDF9 and BMP15 in ovarian tissues from women with polycystic ovary syndrome. J Assist Reprod Genet 2014;31:1483-90.
Allahbadia GN, Merchant R. Polycystic ovary syndrome and impact on health. Middle East Fertility Society Journal 2011;16:19-37.
van der Spuy ZM, Dyer SJ. The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:755-71.
Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction 2006;132:191-206.
Yeo CX, Gilchrist RB, Thompson JG, Lane M. Exogenous growth differentiation factor 9 in oocyte maturation media enhances subsequent embryo development and fetal viability in mice. Hum Reprod 2008;23:67- 73.
Schuchner EB, Pérez Ballester B, Pérez Lloret A. An ultrastructural study of the human micropolycystic ovary. J Reprod Fertil 1978;53:19-21.
Irving-Rodgers HF, Morris S, Collett RA, Peura TT, Davy M, Thompson JG, et al. Phenotypes of the ovarian follicular basal lamina predict developmental competence of oocytes. Hum Reprod 2009;24:936-44.
Wang F, Yu B, Yang W, Liu J, Lu J, Xia X. Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats. J Ovarian Res 2012;5:15.
Erickson AC, Couchman JR. Still more complexity in mammalian basement membranes. J Histochem Cytochem 2000;48:1291-1306.
Knight PG, Glister C. Local roles of TGF-beta superfamily members in the control of ovarian follicle development. Anim Reprod Sci 2003;78:165-83.
Rankin T, Soyal S, Dean J. The mouse zona pellucida: folliculogenesis, fertility and pre-implantation development. Mol Cell Endocrinol 2000;163:21-5.
Wassarman PM, Litscher ES. Influence of the zona pellucida of the mouse egg on folliculogenesis and fertility. Int J Dev Biol 2012;56:833-9.
Meczekalski B, Nawrot R, Nowak W, Czyzyk A, Kedzia H, Gozdzicka- Jozefiak A. Study on the zona pellucida 4 (ZP4) gene sequence and its expression in the ovaries of patients with polycystic ovary syndrome. J Endocrinol Invest 2015;38:791-7.